Shitara, K., Janjigian, Y. Y., Elimova, E., Zhang, J., Chen, M., Smyth, E. C., Lee, J., Miao, R., Liu, S., Holmblad, M., Rahma, O. E., Xu, R. (2026). CLARITY-Gastric 01: A randomized phase 3 study of sonesitatug vedotin (sone ve), a Claudin18.2 (CLDN18.2)-targeted antibody-drug conjugate, in second- or later-line (2L+) advanced gastric or gastroesophageal junction cancer (GC/GEJC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps462